Relevium´s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America
(WorldNews Canada)

MONTREAL, June 26, 2019 (GLOBE NEWSWIRE) - Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: `RLV `, OTCQB: `RLLVF` and Frankfurt: `6BX` (the `Company` or `Relevium`) announced today it is positioning itself as an important player in the Colombian medical cannabis market by cementing medical and research relationships in the country in order to establish clinical validation programs for its Endo Nutraceutical Supplements (ENS) and Oral Nutritional Supplements.On June 13th, 2019, the Company announced a binding LOI to acquire LifeLine Pharma SAS, a binding agreement to acquire the shares of Lifeline Pharma SAS, a Cali based cultivation and extraction business...